5 Ovarian Cancer Clinical Trials in Hackensack, NJ (2026)

Q: How do I join a clinical trial in Hackensack?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hackensack research site will contact you.

Recruiting Ovarian Cancer Studies in Hackensack

NCT06276491Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will al...

Hackensack, NJPHASE1282 participantsXencor, Inc.

View Study Details

NCT06476808Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

The purpose of this study is to evaluate the safety, tolerability, and efficacy of escalating doses of BMS-986463 in participants with select advanced malignant tumors....

Hackensack, NJPHASE1240 participantsBristol-Myers Squibb

View Study Details

NCT06515613Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-engaging bispecific antibody , in participan...

Hackensack, NJPHASE1156 participantsContext Therapeutics Inc.

View Study Details

NCT06774963Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

This is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and / or recommended phase 2 dose of LNCB74 i...

Hackensack, NJPHASE1145 participantsNextCure, Inc.

View Study Details

NCT06469281Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

This study is researching an experimental CAR T cell therapy called 27T51, referred to as study drug. The study drug is a MUC16 targeting immune cell therapy focused on adult female participants with ...

Hackensack, NJPHASE190 participantsRegeneron Pharmaceuticals

View Study Details

About Ovarian Cancer Clinical Trials in Hackensack

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 5 ovarian cancer clinical trials recruiting participants in Hackensack, NJ. These studies are seeking a combined 913 participants. Research is being sponsored by Xencor, Inc., Bristol-Myers Squibb, Context Therapeutics Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in Hackensack — FAQ

Are there ovarian cancer clinical trials in Hackensack?

Yes, there are 5 ovarian cancer clinical trials currently recruiting in Hackensack, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hackensack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hackensack research site will contact you about next steps.

Are clinical trials in Hackensack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hackensack studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 5 active trials in Hackensack are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated July 20, 2026 from ClinicalTrials.gov